Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.

Summary

This phase I clinical trial is used to evaluate the safety of Andiabet, a herbal-derived medicinal product that assists in the treatment of type 2 Diabetes (T2D). Thereby, determine efficacy of the drug on stabilizing blood glucose in T2D patients.

Timeline

Start

2018-11-24

Primary completion

2019-02-22

Completion

2019-02-22

Drugs

Indications